Amyotrophic lateral sclerosis (ALS): Evaluation of respiratory function;Sclérose latérale amyotrophique (SLA): Évaluation des fonctions ventilatoires

Revue Neurologique

Volumn 162, Issue HS2, 2006, Pages

  Perez, T ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Amyotrophic lateral sclerosis; Arterial blood gases; Nocturnal oxymetry; Respiratory muscles; Spirometry

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; APNEA; CONFERENCE PAPER; CORRELATION COEFFICIENT; COUGHING; DIAGNOSTIC ACCURACY; DIAPHRAGM PARALYSIS; FORCED EXPIRATORY VOLUME; HUMAN; HYPERCAPNIA; HYPOVENTILATION; LUNG FUNCTION TEST; MUSCLE STRENGTH; MUSCLE WEAKNESS; OXIMETRY; PROGNOSIS; RESPIRATORY FUNCTION; SPIROMETRY; STATISTICAL SIGNIFICANCE; VITAL CAPACITY; BREATHING; CONSENSUS DEVELOPMENT; PATHOPHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; RESPIRATION; RESPIRATORY FUNCTION TESTS;

EID: 33749662477     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. ARNULF I, MEHIRI S, ATTALI V et al. (2000). Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 161 : 849-856.
2. ATS/ERS. (2002). Statement on respiratory muscle testing. Am J Respir Crit Care Med, 166 : 518-624.
3. BACH JR, ISHIKAWA Y, KIM H. (1997). Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. CHEST, 122: 1024-1028.
4. BENDITT JO. (2002). Respiratory complications of amyotrophic lateral sclerosis. Sem Respir Crit Care Med, 23 : 239-247.
5. BLACK LF, HYATT RE. (1971). Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis, 103: 641-649.
6. BORG GAV. (1982). Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 14 : 377-381.
7. BOURKE SC, SHAW PJ, GIBSON GJ. (2001). Respiratory function vs sleep disordered breathing as predictors of QOL in ALS. Neurology, 57 : 2040-2044.
8. BOURKE, S.C. AND GIBSON GJ. (2002). Sleep and breathing in neuromuscular disease. Eur Respir J, 19 : 1194-1201.
9. BOURKE SC, BULLOCK RE, WILLIAMS TL, SHAW PJ, GIBSON GJ. (2003). Noninvasive ventilation in ALS : indications and effect on quality of life. Neurology, 61 : 171-177.
10. BOURKE SC, MC COLL E, SHAW PJ, GIBSON GJ. (2004). Validation of quality of life instruments in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord, 5: 55-60.
11. CATCHESIDE PG, ORR S, CHIEN CHLONG S, MERCER J, SAUNDERS NA, MC EVOY RD. (2002). Noninvasive cardiovascular markers of acoustically induced arousal from non rapid eye movement sleep. Sleep, 25 : 67-74.
12. CHEN HI, TANG YR. (1989). Sleep loss impairs inspiratory muscle endurance. Am Rev Respir Med, 140 : 907-909.
13. CHAUDRI MB, LIU C, WATSON L, JEFFERSON D, KINNEA WJ. (2000). Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease. Eur Respir J, 15 : 539-542.
14. CONSENSUS CONFERENCE. (1999). Clinical indications for non invasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD and nocturnal hypoventilation - A consensus conference report. Chest, 116 : 521-534.
15. DANEL-BRUNAUD V, PEREZ T, JUST N, DESTÉE A. (2005). Surveillance et traitement des troubles respiratoires associés à la sclérose latérale amyotrophique. Rev Neurol, 161 : 480-85.
16. DESPORT JC, PREUX PM, TRUONG TC, VALLAT JM, SAUTEREAU D, COURATIER P. (1999). Nutritional status is a pronostic factor for survival in ALS patients. Neurology, 53: 1059-1063.
17. EATON T, RUDKIN S, GARRETT JE. (2001). The clinical utility of arterialized earlobe capillary blood in the assessment of patients for long term oxygen therapy. Respir Med, 95: 655-660.
18. ELMAN LB, SIDEROWF AD, MCCLUSKEY LF. (2003). Nocturnal oxymetry: utility in the respiratory management of amyotrophic lateral sclerosis. Am J Phys Med Rehabil, 82: 866-870.
19. FALLAT RJ, JEWITT B, BASS M. (1979). Spirometry in amyotrophic lateral sclerosis. Arch Neurol, 36: 74-80.
20. FARRERO E, PRATS E, PODEVANO M, MARTINEZ-MATOS JA, MANRESA F, ESCARRABIL J. (2005). Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest, 127: 2132-2138.
21. FERGUSON KA, STRONG MJ, AHMAD D, GEORGE CF. (1993). Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest, 110: 664-669.
22. FITTING JW, PAILLEX R, HIRT L, AEBISCHER P, SCHLUEP M. (1999). Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol, 46: 887-893.
23. GAY P, WESTBROOK P, DAUBE J. (1991). Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc, 66: 686-694.
24. GONZALEZ-BERMEJO, PEREZ T. (2005). Homogénéisation de la prise en charge respiratoire des patients SLA en France. Rev Mal Respir, 22: 156-158.
25. GROTE L, ZOU D, KRAICZI H, HEDNER J. (2003). Finger plethysmography: a method for monitoring finger blood flow during sleep disordered breathing. Respir Physiol; 136: 141-152.
26. HART N, POLKEY MI, SHARSHAR T, FALAIZE L, FAUROUX B, RAPHAEL JC, LOFASO F. (2003). Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry, 74: 1685-1687.
27. HUKINS DA, HILLMAN DR. (2000). Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med, 161: 166-170.
28. JUST N, BRUNAUD V, MATRAN R, WALLAERT B, PEREZ T. (2003). Sniff nasal pressure (SNIP) vs spirometry to detect sleep desaturations or daytime hypercapnia in amyotrophic lateral sclerosis (ALS). Eur Respir J, 22: 470s (abstract).
29. KIMURA K, TACHIBANA N, KIMURA J, SHIBASAKI H. (1999). Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci, 164: 37-43.
30. LECHTZIN N, WIENER CM, SHADE DM, CLAWSON L, DIETTE GB. (2002). Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest, 121: 436-442.
31. LYALL RA, DONALDSON N, LEIGH N, MOXHAM J. (2001). Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain, 124: 2000-2013.
32. MAITRE B, SIMILOWSKI T, DERENNE JP. (1995). Physical examination of the adult patient with respiratory diseases: inspection and palpation. Eur Respir J, 8: 1584-1593.
33. MIER-JEDRZEJOWICZ A, BROPHY C, MOXHAM J, GREEN M. (1988). Assessment of diaphragm weakness. Am Rev Respir Dis, 137: 877-883.
34. MILLER RG, ROSENBERG JA, GELINAS DF et al. (1999). Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology, 52: 1311-1323.
35. MORGAN RK, MCNALLY S, ALEXANDER M, CONROY R, HARDIMAN O, COSTELLO RW. (2005). Use of sniff nasal inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 171: 269-274.
36. NEWSOM-DAVIS IC, LYALL RA, LEIGH PN, GOLDSTEIN RH. (2001). The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis: a prospective study. J Neurol neurosurg, 71: 482-487.
37. PEPIN JL, CHOURI-PONTAROLLO N, ORLIAGUET O, LEVY P. (2005). Alveolar hypoventilation during sleep and domiciliary assisted ventilation. Rev Mal Respir, 22: 113-25.
38. PEREZ T. (2005). Exploration de première intention des muscles respiratoires. Rev Mal Respir, 22: 2S37-46.
39. PERRIN C, UNTERBORN JN, D'AMBROSIO C, HILL NS. (2004). Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve, 29: 5-27.
40. PINTO AC, DE CARVALAO M, EVANGELISTA T, LOPES A, SALES-LUIS L. (2003). Nocturnal pulse oxymetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord, 4: 31-35.
41. POLKEY MI, LYALL RA, GREEN M, LEIGH PN, MOXHMA J. (1998). Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 158: 734-741.
42. SANCHO J, SERVERA E, DIAZ J, MARIN J. (2004a). Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest, 125: 1400-1405.
43. SANCHO J, SERVERA E, DIAZ J, MARIN J. (2004b). Comparison of peak cough flows measured by pneumotachograph and a portable peak flow meter. Am J Phys Med Rehabil, 83: 608-612.
44. SCHIFFMAN PL, BELSH JM. (1993). Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration. Chest, 103: 508-13.
45. SCHLOSSHAN D, ELLIOTT MW. (2004). Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome. Thorax, 59: 347-52.
46. SIMILOWSKI T, ATTALI V, BENSIMON G et al. (2000). Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J, 15: 332-337.
47. STAMBLER N, CHARATAN M, CEDARBAUM JM. (1998). Pronostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology, 50: 66-72.
48. SZEINBERG A, TABACHNIK E, RASHED N, MCLAUGHLIN FJ, ENGLAND S, BRYAN CA, LEVISON H. (1988). Cough capacity in patients with muscular dystrophy. Chest, 94: 1232-1235.
49. TZENG AC, BACH JR. (2000). Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest, 118: 1390-1396.
50. ULDRY C, FITTING JW. (1995). Maximal values of sniff nasal inspiratory pressure in healthy subjects. Thorax, 50: 371-375.
51. VARRATO J, SIDEROWF A, DAMIANO P, GREGORY S, FEINBERG D, MCCLUSKEY L. (2001). Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology, 57: 357-359.
52. VELASCO R, SALACHAS F, MUNERATI E et al. (2002). Oxymétrie nocturne chez les patients atteints de sclérose latérale amyotrophique : rôle pronostique. Rev Neurol, 158: 575-578.
53. VITTACA M, CLINI E, FACCHETTI D, PAGANI M, POLONI M, PORTA R, AMBROSINO N. (1997). Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. Eur. Resp. J, 10: 1614-1621.